Skip to main content

Table 1 Disease latency and frequency

From: Impairment of alternative splice sites defining a novel gammaretroviral exon within gagmodifies the oncogenic properties of Akv murine leukemia virus

Virus Average latency period (days) Frequency of mice developing hematopoitic tumors
Akv-wt 184 ± 26 40/40
Akv-CD 201 ± 30 17/19
Akv-EH 184 ± 34 17/18
Akv-CDH 190 ± 46 14/16